Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 CHF | +5.00% | -0.30% | -2.33% |
Mar. 15 | Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024 | |
Mar. 15 | Molecular Partners Swings to Loss in FY23; Revenue Down | MT |
Sales 2024 * | 13.86M 15.18M | Sales 2025 * | 18.66M 20.44M | Capitalization | 105M 115M |
---|---|---|---|---|---|
Net income 2024 * | -59M -64.63M | Net income 2025 * | -61M -66.82M | EV / Sales 2024 * | 7.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.64 x |
P/E ratio 2024 * |
-1.89
x | P/E ratio 2025 * |
-1.72
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.11% |
Latest transcript on Molecular Partners AG
1 day | -1.84% | ||
1 week | -4.48% | ||
Current month | -12.93% | ||
1 month | -13.51% | ||
3 months | -20.00% | ||
6 months | -8.31% | ||
Current year | -6.98% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 04-11-22 | |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Michael Pitzner
CMP | Compliance Officer | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 17-10-30 |
Steven Holtzman
BRD | Director/Board Member | 70 | 14-09-18 |
Vito Palombella
BRD | Director/Board Member | 61 | 20-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.36 | +5.00% | 3 521 |
24-04-25 | 3.2 | -1.84% | 20,118 |
24-04-24 | 3.26 | -4.54% | 3,428 |
24-04-23 | 3.415 | +3.48% | 3,527 |
24-04-22 | 3.3 | -2.08% | 355 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.98% | 115M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.84% | 22.02B | |
-17.84% | 20.9B | |
-9.98% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- MOLN Stock